Company Active LTD

Company profile

Manchester Imaging Limited

AI Dental Software | Improves Caries Detection | AssistDent

Ground-breaking AI dental diagnostic software to help increase early detection rates of caries. AssistDent for preventive dentistry.

CRN
09098192
Founded
2014
Age
12

Overview

Legal name
MANCHESTER IMAGING LIMITED
Region
Unknown
Registered address
C/O NEXUS SOLICITORS CARLTON HOUSE
16-18 ALBERT SQUARE
MANCHESTER
ENGLAND
M2 5PE
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
4

Company events

Reference milestones and recent Companies House filing stream events.

5 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

06 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

22 Jun
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

23 Jun
2014

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2014
Funded years
2014, 2020, 2023
Age at first award
0 years

Projects

2023 Collaborative R&D Lead participant

Osteodent-AI: A Revolutionary Approach to Osteoporosis Detection

1 Oct 2023 to 31 Jan 2025

Awarded
£348,135
Total cost £497,336

Osteoporosis is a health condition that weakens bones, making them fragile and more likely to fracture. It develops slowly over several years, or even decades, without symptoms and is often only diagnosed when a fall or sudden impact causes a bone fracture. According to the International Osteoporosis Foundation, 1 in 3 women and 1 in 5 men over the age of...

2020 Feasibility Studies Lead participant

AI-based self-directed distance learning for dental students

1 Jun 2020 to 31 Mar 2021

Awarded
£70,914
Total cost £70,914

The project focus is global education of dental studentsat university dental schools. This sector is badly impactedby the current pandemic, struggling to maintain many aspects of dental student education and anticipating difficulties recovering functionally and economically in the aftermath and future years. There are 17 university dental schools in the U...

2014 GRD Proof of Market Lead participant

Osteodent: Proof of Market

1 Nov 2014 to 30 Apr 2015

Awarded
£23,900
Total cost £39,900

We wish to investigate the commercial viability of the idea for a new product, ‘OSTEODENT’, enabling the early detection of osteoporosis from dental radiographs and clinical risk factors. The impact of OSTEODENT in reducing the health burden of osteoporosis could be significant if it is used to detect early signs of osteoporosis and allow preventative tre...

Product types

Collaborative R&D Feasibility Studies GRD Proof of Market